Showing 1 - 12 results of 12 for search 'Jose Luis Revuelta', query time: 0.05s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital by Cristina Villanueva-Bueno, Cristina Villanueva-Bueno, Roberto Collado-Borrell, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Vicente Escudero-Vilaplana, José Luis Revuelta-Herrero, José Luis Revuelta-Herrero, María Belén Marzal-Alfaro, María Belén Marzal-Alfaro, Eva González-Haba, Eva González-Haba, José Ángel Arranz-Arija, José Ángel Arranz-Arija, Santiago Osorio, Santiago Osorio, Ana Herranz-Alonso, Ana Herranz-Alonso, María Sanjurjo-Saez, María Sanjurjo-Saez
Published 2022-11-01
Article -
7
Uncovering Arabidopsis membrane protein interactome enriched in transporters using mating-based split ubiquitin assays and classification models by Jin eChen, Jin eChen, Sylvie eLalonde, Petr eObrdlik, Azam eNoorani Vatani, Saman A Parsa, Cristina eVilariño, Jose Luis Revuelta, Wolf B Frommer, Seung Y Rhee
Published 2012-06-01
Article -
8
Genome-wide analysis of factors affecting transcription elongation and DNA repair: a new role for PAF and Ccr4-not in transcription-coupled repair. by Hélène Gaillard, Cristina Tous, Javier Botet, Cristina González-Aguilera, Maria José Quintero, Laia Viladevall, María L García-Rubio, Alfonso Rodríguez-Gil, Antonio Marín, Joaquín Ariño, José Luis Revuelta, Sebastián Chávez, Andrés Aguilera
Published 2009-02-01
Article -
9
A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application by Sebastián García-Sánchez, Roberto Collado-Borrell, Eva González-Haba, José Luis Revuelta-Herrero, Vicente Escudero-Vilaplana, María Belén Marzal-Alfaro, María Norberta Sánchez-Fresneda, Ana Mur-Mur, Ana Herranz, Miguel Martín, María Sanjurjo
Published 2022-06-01
Article -
10
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy by Elena Ramos-Ruperez, Vicente Escudero-Vilaplana, Vicente Escudero-Vilaplana, Paula Ruiz-Briones, Paula Ruiz-Briones, Roberto Collado-Borrell, Roberto Collado-Borrell, Cristina Villanueva-Bueno, Cristina Villanueva-Bueno, José Luis Revuelta-Herrero, José Luis Revuelta-Herrero, Eva González-Haba, Eva González-Haba, Xandra Garcia-Gonzalez, Xandra Garcia-Gonzalez, Sara Ibañez-Garcia, Sara Ibañez-Garcia, Sara Perez-Ramirez, Sara Perez-Ramirez, Eduardo Zatarain-Nicolás, Eduardo Zatarain-Nicolás, Eduardo Zatarain-Nicolás, Eduardo Zatarain-Nicolás, Ana Herranz, Ana Herranz, María Sanjurjo, María Sanjurjo
Published 2023-08-01
Article -
11
<i>DPYD</i> Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach by Priscila Villalvazo, Belén Marzal-Alfaro, Pilar García-Alfonso, José Luis Revuelta-Herrero, Fabienne Thomas, Sara López-Tarruella, Xandra García-González, Aitana Calvo, Malika Yakoubi, Sara Salvador-Martín, Flora López-López, Iker Aguilar, María Sanjurjo-Sáez, Miguel Martín, Luis Andrés López-Fernández
Published 2021-08-01
Article -
12
Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Thera... by Vicente Escudero-Vilaplana, Vicente Escudero-Vilaplana, Lorena Romero-Medrano, Lorena Romero-Medrano, Cristina Villanueva-Bueno, Cristina Villanueva-Bueno, Marta Rodríguez de Diago, Alberto Yánez-Montesdeoca, Roberto Collado-Borrell, Roberto Collado-Borrell, Juan José Campaña-Montes, Juan José Campaña-Montes, Belén Marzal-Alfaro, Belén Marzal-Alfaro, José Luis Revuelta-Herrero, José Luis Revuelta-Herrero, Antonio Calles, Antonio Calles, Mar Galera, Mar Galera, Rosa Álvarez, Rosa Álvarez, Ana Herranz, Ana Herranz, María Sanjurjo, María Sanjurjo, Antonio Artés-Rodríguez, Antonio Artés-Rodríguez, Antonio Artés-Rodríguez, Antonio Artés-Rodríguez
Published 2022-07-01
Article